⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of QIAGEN N.V. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
QIAGEN N.V.
↗Venlo, Netherlands
QIAGEN is a global leader in 'Sample to Insight' solutions, providing technologies that isolate, purify, and analyze DNA, RNA, and proteins from biological samples. The company serves over 500,000 customers worldwide, ranging from academic research and pharmaceutical development to molecular diagnostics and applied testing (forensics, food safety).
Headquartered in Venlo, Netherlands, with operational headquarters in Hilden, Germany, QIAGEN offers a comprehensive portfolio including instrumentation, consumables, and bioinformatics software. Their solutions are critical for applications such as oncology profiling, infectious disease identification, and personalized healthcare through companion diagnostics.
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Life Sciences Tools & Diagnostics
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$2.1B
Founded:1984
Ownership:public
Status:operating
STOCK
Exchange:NYSE
Ticker:QGEN
Market Cap:$8.56B
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Diagnostics/Tools Provider)
Modalities:NGS, PCR, Digital PCR, Bioinformatics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Pharmaceutical and biotechnology companies (for companion diagnostics development)
COMPETITION
Position:Leader
Competitors:Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Roche Diagnostics, Agilent Technologies
LEADERSHIP
Key Executives:
Thierry Bernard - CEO
LINKS
Website:qiagen.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with QIAGEN N.V.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.